DEFINITIVE PROXY STATEMENT

Company

LIFECORE BIOMEDICAL, INC. \DE\

Filed

August 30, 2012

Period of Report

October 11, 2012

Accession Number

0001437749-12-009024

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →